相似文献
1
Oral sulfonylureas for the treatment of type II diabetes: an update.
South Med J. 1986 Mar;79(3):337-43. doi: 10.1097/00007611-198603000-00019.
2
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Clin Pharm. 1984 Sep-Oct;3(5):473-85.
3
The second generation sulfonylureas: glipizide and glyburide.
Diabetes Educ. 1985 Fall;11(3):29-36. doi: 10.1177/014572178501100305.
4
The second generation oral sulfonylureas: glyburide and glipizide.
Am Pharm. 1988 Oct;NS28(10):55-61.
5
Glipizide and glyburide.
N C Med J. 1986 Mar;47(3):149-53.
6
Clinical pharmacology of glipizide.
Am J Med. 1983 Nov 30;75(5B):41-5. doi: 10.1016/0002-9343(83)90252-8.
7
Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
Pharmacotherapy. 1985 Mar-Apr;5(2):63-77. doi: 10.1002/j.1875-9114.1985.tb03405.x.
8
Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
Diabetes Care. 1987 Nov-Dec;10(6):679-82. doi: 10.2337/diacare.10.6.679.
9
The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
W V Med J. 1990 Oct;86(10):455-8.
10
Oral hypoglycemic agents in the treatment of type II diabetes.
Am Fam Physician. 1993 Nov 1;48(6):1089-95.
引用本文的文献
1
The management of diabetes mellitus in older individuals.
Drugs. 1991 Apr;41(4):548-65. doi: 10.2165/00003495-199141040-00004.
Zotero 插件